new glp-1 agonists receptor and next-generation metabolic hormone therapies in chronic kidney disease GLP-1 Receptor Agonists as Treatments

in: PubMed | Google Scholar | Authorship note: BW and COS are cofirst authors

The impact of gastroparesis from Ozempic can result in very different consequences, with some users requiring prolonged hospitalization and being left with permanent disabilities

The glucagon-like peptide-1 system is modulated by acute and chronic alcohol exposure: Findings from human laboratory experiments and a post-mortem brain study

Functional differences between microglia and monocytes after ischemic stroke

Is hair loss reversible after stopping weight loss drugs

The most commonly reported adverse events in the retatrutide groups were gastrointestinal, including nausea, diarrhea, and vomiting